Maverick Capital Ltd
Source: SEC Form 13F · as of Mar 2026Maverick Capital Ltd holds 8 biotech & pharma companies tracked by BioSniper, totaling $318.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
8
Total value held
$318.8M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Vaxcyte, Inc. (PCVX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| PCVXVaxcyte, Inc. | 1,377,738 | $80.1M |
| CNTACentessa Pharmaceuticals plc | 1,854,488 | $73.7M |
| NAMSNEWAMSTERDAM PHARMA CO N.V. | 2,186,402 | $70.0M |
| ROIVRoivant Sciences Ltd. | 1,626,940 | $45.1M |
| IVVDInvivyd, Inc. | 18,970,913 | $24.7M |
| RCKTRocket Pharmaceuticals Inc. | 3,567,372 | $12.8M |
| QUREuniQure N.V. | 697,640 | $11.4M |
| SNYSanofi | 24,581 | $1.2M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.